cagrilintide 2.5 mg + Samaglutide 2.5 mg
A co-formulated treatment combining Cagrilintide (an amylin analog) and Semaglutide (a GLP-1 agonist). The synergetic effect targets multiple metabolic pathways to suppress appetite heavily and maximize body weight reduction.
Verifying a batch
Match the batch code on the vial to a third-party certificate of analysis showing both purity and identity.
Search lab reports for this compound →How purity is tested →
Looking for cagrilintide 2.5 mg + Samaglutide 2.5 mg?
Join our next group buy to get verified quality at wholesale prices.
All compounds listed here are supplied for laboratory research use only and are not medicines, supplements, or products for human consumption.